Wednesday, May 22, 2013 Last update: 1:43 AM
Company Tech News as it Breaks
SARcode Bioscience, Inc.
News articles for SARcode Bioscience, Inc.:
Monday, March 25, 2013
- SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.BRISBANE, Calif., March 25, 2013 /PRNewswire/ -- SARcode Bioscience, Inc., an ophthalmic biopharmaceutical company, announced today that it will be acquired by Shire US Holdings Inc., a global specialty biopharmaceutical company focused on enabling people with life-altering conditions to lead better lives. SARcode's lead program, ... read more
Tuesday, January 8, 2013
- First Subject Enrolled in OPUS-2, SARcode Bioscience's Second Pivotal Study of Lifitegrast Ophthalmic SolutionBRISBANE, Calif., Jan. 8, 2013 /PRNewswire/ -- SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today that the initial subject has been enrolled in a second pivotal Phase 3 clinical efficacy study (OPUS-2) of lifitegrast ophthalmic solution 5.0%. OPUS-2 will assess the efficacy and safety ... read more